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Abstract 
 
Background: This position statement provides clinical recommendations for the assessment of pain, 
level of sedation, iatrogenic withdrawal syndrome and delirium in critically ill infants and children. 
Admission to a neonatal or paediatric intensive care unit (NICU, PICU) exposes a child to a series of 
painful and stressful events. Accurate assessment of the presence of pain and non-pain related 
distress (adequacy of sedation, iatrogenic withdrawal syndrome, and delirium) is essential to good 
clinical management and to monitoring the effectiveness of interventions to relieve or prevent pain 
and distress in the individual patient.  
Methods: A multidisciplinary group of experts was recruited from the members of the European 
Society of Paediatric and Neonatal Intensive Care (ESPNIC). The group formulated clinical questions 
regarding assessment of pain and non-pain related distress in critically ill and non-verbal children, 
and searched the PubMed/Medline, Cinahl, and Embase databases for studies describing the 
psychometric properties of assessment instruments. Further, level of evidence of selected studies 
was assigned and recommendations were formulated, and grade or recommendations were added 
based on the level of evidence.  
Results: An ESPNIC Position Statement was drafted which provides clinical recommendations on 
assessment of pain (n=5), distress and/or level of sedation (n=4), iatrogenic withdrawal syndrome 
(n=3), and delirium (n=3). These recommendations were based on the available evidence and 
consensus amongst the experts and other members of the ESPNIC society.  
Conclusions: This multidisciplinary ESPNIC Position Statement guides professionals in the assessment 
and re-assessment of the effectiveness of treatment interventions for pain, distress, inadequate 
sedation, withdrawal syndrome and delirium. 
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Introduction 
This position statement provides clinical recommendations for the assessment of pain, level of 
sedation, iatrogenic withdrawal syndrome and delirium in critically ill infants and children. Admission 
to a neonatal or paediatric intensive care unit (NICU, PICU) exposes a child to a series of painful and 
stressful events. The effects of these events are commonly resolved by the administration of 
aŶalgesiĐs ;e.g. ŵorphiŶe, feŶtaŶǇlͿ aŶd/or sedatiǀes ;e.g. ďeŶzodiazepiŶes, αϮ seleĐtiǀe adreŶergiĐ 
agonists) [1]. However, sedation with benzodiazepines in neonates is advised against in view of the 
unfavourable patient outcomes [2]. A recent survey showed wide variety in both the dosages and 
choices of drugs administered to neonates [3]. While adequate analgesia and sedation help reduce 
the stress response and improve the clinical and psychological outcomes [4] inadequate analgesia 
and sedation will lead to pain, pain-induced agitation or under-sedation and possibly to accidental 
extubation or removal of vascular access devices. Overuse of analgesic and sedative agents, on the 
other hand, can lead to over-sedation, prolonged ICU stay, longer ventilation times, drug tolerance 
and dependence. Furthermore, iatrogenic withdrawal syndrome and delirium could be identified as 
side effects of prolonged analgesia and sedation  [5, 6]. Both are considered as concepts of non-pain 
related distress in critically ill children.  The current clinical guidelines on analgesic and sedative drugs 
use in adult and paediatric ICU populations [7, 8] are based on evidence of highly variable level.  
Accurate and regular measurement of pain and non-pain related distress is essential, not only to 
establish their presence but also to monitor the effectiveness of interventions. Accurate and regular 
measurement of pain and non-pain related distress is essential to establish their presence [9]. 
Furthermore, the effectiveness of pharmacological interventions should be monitored because this 
may be affected by the specific pharmacokinetics and pharmacodynamics in the individual critically ill 
child [10]. The gold standard of assessing patient comfort is self-reporting. Self-report is impossible, 
however, in pre-verbal and non-verbal children who are often sedated or when a tracheal tube is in 
place. In these cases, healthcare professionals must resort to observing the Đhild’s phǇsiologiĐal aŶd 
behavioural responses. Still, healthcare professionals’ observations and assessments of pain and non-
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pain related distress will depend on their ideas and beliefs on discomfort, pain, best drugs and 
treatment, and on their knowledge. On the other hand, as we know from adults [11], it may be 
difficult to discriminate between pain, distress, IWS and delirium in critically ill children, because the 
behavioral cues will overlap in part (Figure 1).  Therefore, standardized assessment tools have been 
proposed and validated so as to limit avoidable variability in assessment [12]. In practice, a patient’s 
individual analgesia and sedation requirements will be assessed by different nurses, with varying 
degrees of expertise, which may lead to inconsistent dosing of sedatives and analgesics [13]. Use of a 
standard tool may counteract this effect and promote continuity of care [14].  
 This position paper specifically provides clinical recommendations for NICU and PICU healthcare 
clinicians on the assessment of pain, sedation, withdrawal and delirium in their patients. 
 
 
Methods 
A multidisciplinary group of expert clinicians and researchers in the fields of pain, sedation, 
withdrawal syndrome and delirium were recruited from the membership of the European Society of 
Paediatric and Neonatal Intensive Care (ESPNIC) to develop the position statement. The process of 
formulating the clinical recommendation comprised the following steps. First, questions were 
formulated regarding the clinical practice of assessment of pain related and non-pain related distress 
(e.g. adequacy of sedation, iatrogenic withdrawal syndrome, and delirium) in critically ill and non-
verbal children. Second, an extensive search of the literature on assessment tools was performed to 
find evidence for recommendations. For this reason, the PubMed/Medline, Cinahl, and Embase 
databases were searched using the following MeSH and all fields search terms: (pain measurement, 
distress, sedation, substance withdrawal syndrome, delirium) AND (paediatric critical care OR 
neonatal intensive care) (See Appendix for search strategy). The search scope was limited to studies 
in the English or French language published between August 2005 and August 2015, so as to 
provided the most up to date relevant research, that included paediatric or neonatal critical care 
6 
 
non-verbal inpatients, with the age limits set from birth to 18 years. Neonates were included, as they 
can be admitted to PICUs in some European settings. In the past decades more than 40 neonatal pain 
assessment tools have been developed and validated. From two recent systematic reviews we 
derived the most recent evidence of the psychometric properties of neonatal pain (e.g. acute, 
prolonged pain) assessment instruments [15, 16]. Based on this, we described the psychometric 
properties of the most commonly used neonatal instruments. Additional search terms, such as pain 
questionnaires, pain scales, pain tools, pain instruments and search of authors known in the field 
served to verify completeness of the search results. Cross-referencing of key articles and recently 
published systematic reviews describing psychometric properties of assessment instruments [17, 18] 
served as a final check. Prior to full-text retrieval, studies describing the psychometric properties of 
instruments to assess physiological and behavioural cues of pain related and/or non-pain related 
distress were selected based on the title and abstract. Studies that did not report on psychometric 
properties of the tools and those that only reported on neonatal abstinence syndrome were 
excluded. 
In the third phase, each of the articles selected was subjected to an independent Grade of Evidence 
Review by at least two of the authors and differences in grading were resolved through discussion. 
The level of the evidence was assigned a grade using the definitions is provided in a supplementary 
Table and based on reference test, specific research design, and methodology [19]. Subsequently, 
recommendations for assessment of pain related and non-pain related distress in children were 
formulated and discussed by the group during a meeting. The Recommendations were assigned 
according to the level of evidence. Lastly, to achieve consensus the draft Position Statement was 
reviewed by independent members of the ESPNIC Nursing Science section (Pain & Sedation study 
group) and the Pharmacology section; they graded the importance of the statements related to the 
topic area. This process did not lead to any fundamental changes. The final version was endorsed by 
the Executive Board of ESPNIC.  
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This position statement puts a focus on the assessment of 1) pain-related distress, and 2) non-pain 
related distress (level of sedation, withdrawal, and delirium) in the NICU/PICU as a first essential step 
in the management of pain and distress in these vulnerable populations.  
 
 
RESULTS 
Evidence from a total of 32 full-text articles describing the psychometric properties of assessment 
tools for pain related and non-pain related distress in children was used to underpin the 
recommendations in this position statement (see supplementary file). 
 
 
Assessment of pain related distress 
Pain assessment in hospitalised infants and children is notoriously difficult due to the different 
emotional and cognitive development stages of this patient group. Moreover, they are often 
ventilated and sedated, which complicates assessment of behaviours, and interpreting pain related 
behaviours is often subjective, relǇiŶg oŶ the ĐliŶiĐiaŶs’ iŶterpretatioŶ.  
For intensive care settings, we can distinguish two relevant types of pain: 1) acute pain, including 
procedural and postoperative pain (e.g. pain caused heelstick, suctioning, venepuncture, thoracic 
drainage) and postoperative pain; and 2) prolonged pain (see Table 1 for definitions). For clinical 
reasons it is important to explore the underlying pathogenesis and the context of pain (Figure 2). 
However, different types of pain, e.g. neurogenic pain, visceral pain and somatic pain, can not be 
distinguished with the use of observational assessment tools. 
 
Children and neonates in the intensive care setting undergo numerous procedures which potentially 
cause pain, e.g. intravenous cannulation, chest drain insertion, intubation, or discomfort, e.g. from 
invasive monitoring lines. Nurses and physicians should be aware, however, that daily care (e.g. 
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turning) can be painful as well, and that what is considered painful in older children and adults [20] 
should also be considered painful for children and neonates. Neonates are particularly at risk of pain 
exposure with a reported mean of 10.0 to 22.9 procedures per day [21, 22]. Prolonged pain is poorly 
understood, but is characterised by a lack of clear stimulus, a variable duration and slow recovery 
[23].Furthermore it is present after several days of hospitalisation and when no obvious cause for 
pain is present [24].  
Recommendation: 
 Identify potential sources of pain and to take appropriate actions (grade of recommendation = D) 
 
The use of pain assessment instruments has been widely recommended as a means to provide 
consistency between clinicians, to provide an indication that pain/discomfort is present and to assess 
the effect of a pharmacological or non-pharmacological interventions.  
There is limited literature on pain assessment in the PICU; the available studies concern the 
validation of instruments such as the COMFORT scale [25, 26], the COMFORT-B scale
1
 [27-33], the 
FLACC scale [32, 34, 35] and the Multidimensional Assessment Pain Scale (MAPS) [36, 37]. The 
COMFORT-B scale has also been validated for patients with burns [38]. In contrast, more than 40 pain 
assessment instruments for neonates have been developed in the last few decades, but not all meet 
the minimum psychometric requirements for application in clinical practice [16]. The well-
established, validated COMFORT-B scale and the FLACC scale (for infants and children [39] and the 
promising PIPP-R (for neonates) [40, 41] are recommended (See, Table 2, Table 3 and supplementary 
file for their psychometric properties). 
Recommendation:  
                                                          
1
 The COMFORT scale was originally developed for assessing the level of distress in ventilated children. In combination with 
the use of the NRS pain the COMFORT-B scale is suitable to determine the need for analgesia or sedation. 
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 Use an age-appropriate tool to assess acute, and prolonged pain, that is the PIPP(-revised) in 
neonates and the COMFORT behavior scale, (FLACC) or MAPS in critically ill children  (grade of 
recommendation = A) 
 
The vital signs heart rate and mean arterial pressure have been moderately correlated with 
behaviour items [28, 42]. In children, these vital signs are probably less reliable indicators of pain 
than behavioural indicators. In heavily sedated or muscle relaxed children, however, increases in 
heart rate and mean arterial pressure may indicate that the body is under some stress – in the 
absence of behavioural signs pain must be one of the considerations in this scenario, the more so as 
there is no other method to assess these children. 
It must be remembered that in the case of pain or discomfort in the non-verbal child, reflected by a 
high score, the practitioner should acknowledge possibly contributing environmental factors 
(temperature, noise) or other factors such as the need for a change of position, infant teething, or 
the need for nappy care. It is assumed that the nurse will check and modify these environmental 
factors first before making a treatment plan and re-assess once an intervention has taken place. 
 
Studies have shown that parents themselves wish to be more involved in the process of assessing 
pain in their child and urge for more consistent pain assessment and management practices by staff. 
Parents' knowledge of their own child and how they may display pain or distress may enhance 
ĐliŶiĐiaŶ’s assessŵeŶt aŶd ŵaŶageŵeŶt praĐtiĐes. Further research is needed with regard to pain 
assessment involving families. 
Recommendation:  
 Parent and family assessment of pain should be considered to pain assessment (grade of 
recommendation = D) 
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There are no clear-cut recommendations in the literature on the frequency of pain assessment; this 
position statement merely provides the clinician with a consensus on the frequency. Furthermore, 
the frequency of assessment will depend on the goal of therapeutic treatment (e.g. weaning of 
ventilation, transfer to pediatric ward). 
Recommendation:  
 Pain assessment should take place routinely, depending on therapeutic goals, but at greater 
frequency (1-2 hourly) if the patient is receiving any analgesic infusion (grade of recommendation 
= D). 
 
Audits of pain assessment should take place regularly (e.g. every 12 months) to evaluate the quality 
of patient care and patient outcomes [43]. 
Recommendation:  
 Pain assessment audits should take place regularly (grade of recommendation = C). 
 
Non-pain related distress 
Sedation assessment 
Patients admitted to an intensive care unit are likely to develop physical and psychological distress. 
Non-pain related distress in ventilated children is treated with sedatives. Optimal sedation has been 
described as a state in which the patient is somnolent, responsive to the environment but 
untroubled by it, and without excessive movements [13] (Table 1). In practice this means that a child 
is conscious, breathes in synergy with the ventilator, and is tolerant or compliant with other 
therapeutic procedures. Still it can be challenging to reach this level of sedation. A recent systematic 
review revealed that across all studies of paediatric patients (n=25), patients were optimally sedated 
in 58%, undersedated in 10% and oversedated in 32% of the observations [44]. Optimal level of 
sedation varies for each patient and careful consideration should be given to the underlying 
diagnosis and severity of illness [1, 13]. Oversedation may lead to longer duration of mechanical 
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ventilation for a longer period and increased health care costs. On the other hand, undersedation can 
lead to increased distress, self- or accidental extubation, accidental displacements of catheters, tubes 
and vascular access. In clinical practice it can be challenging to reach the optimal level of sedation in 
infants and children. The majority of children in the PICU are below 4 years of age and in view of their 
development not yet able to understand or make sense of their situation, and will easier become 
anxious and scared.  For this reason they often need greater amounts of sedatives to ensure lines 
and tubes remain in situ.  
 
The sedation goal may vary considerably from patient to patient and depends on severity of illness, 
type of disease and treatment as well as environmental factors, such as noise. When a child shows 
signs of agitation and fighting against the ventilator, the child should be sedated after confirmation 
that the ǀeŶtilator settiŶgs are ǁell adjusted to the Đhild’s respiratorǇ Ŷeeds.  
Recommendation: 
 Search for potential causes of non-pain related distress/discomfort to take appropriate actions 
(grade of recommendation = D). 
 
Although clinical judgement of trained ICU professionals is important, the use of a sedation 
assessment tool is needed to determine the efficacy of sedatives and related interventions, to 
facilitate inter-institutional comparisons, and to facilitate targeted sedation. Several behavioural 
sedation scoring scales (e.g. COMFORT scale [25, 45], COMFORT behaviour scale [14, 42], State 
Behaviour Scale [46]) have been described and validated for children (Table 2 and 4, supplementary 
file). Also, these tools are the most common used instruments in daily practice [47]. No single 
instrument has been shown to be superior for use in this population, and it is advisable to select a 
scale that has been validated for this patient population. The frequency of assessment reported in 
the included studies (n=25) varied considerably; i.e. from once daily to hourly [44]. Although the 
frequency of assessment will depend on whether symptoms have been controlled or nor and on the 
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goal of therapeutic treatment (e.g. weaning of ventilation), we recommend regular assessment at 
least once per shift and accurate documentation of the sedation score, we recommend regular 
assessment at least once per shift and accurate documentation of the sedation score. 
Recommendation: 
 Use standardized sedation assessment tools with proven validity, reliability, and clinical utility; 
The COMFORT Behavior scale (grade of recommendation = A). 
 Together with the vital signs, the level of sedation must be assessed and documented every 4 to 8 
hours or as indiĐated ďy the sedation sĐore or the Đhild’s ĐliniĐal Đondition (grade of 
recommendation = D). 
 
Iatrogenic withdrawal syndrome assessment in infants and children 
Prolonged administration of opioids and/or benzodiazepines in infants and children may induce drug 
tolerance and physiological dependency. Abrupt discontinuation or (too rapid) weaning of these 
drugs in physically dependent infants and children may result in iatrogenic withdrawal syndrome 
(IWS) (Table 1) [6, 48]. 
Tolerance and withdrawal symptoms may occur after 5 or more days of continuous infusion of 
opioids or benzodiazepines in infants as well as children. The onset of withdrawal can occur after 1 
up to 48 hours after tapering off or discontinuation [6, 48]. An estimated 10% to 34% of all PICU 
patients are at risk for IWS [49, 50]. Fentanyl and morphine are the most frequently used analgesic 
drugs in the NICU and PICU that underlie opiate IWS, with prevalence rates of 9% to 57% [51, 52]. 
The reported prevalence rates of IWS in PICU patients who had received benzodiazepines and/or 
opioids for 5 or more days range from 35% to 57% [53, 54]. 
Recommendation: 
 The potential risk of opioid and/or benzodiazepine iatrogenic withdrawal syndrome should be 
considered after 5 days of continuous administration of these drugs (grade of recommendation = 
C).  
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Diagnosing withdrawal symptoms in NICU and PICU patients is complicated by the fact that these 
symptoms may overlap with clinical signs of pain or distress, respiratory distress, delirium and noise-
induced stress [6, 55, 56]. These other factors must be excluded before the diagnosis can be 
confirmed. Regarding the fact that IWS may occur after 5 days, we recommend to continue 
assessment of withdrawal symptoms after the child has been discharge from the PICU. 
Two instruments for assessing IWS in children have been sufficiently validated, namely: the 
Withdrawal Assessment Tool version 1 (WAT-1) [57, 58] and the Sophia Observation withdrawal 
Symptoms-scale (SOS) [59, 60]. The WAT-1 is an 11-item scale and scores of three or higher (on a 
scale of 0–12) indicate that the child is suspected for withdrawal. The SOS consists of 15 items and is 
based on the underlying empirical structure of co-occurrences of withdrawal symptoms that experts 
considered relevant. A SOS score of 4 or higher reflects a high probability of withdrawal. Table 5 and 
supplementary file provide details on symptoms and the psychometric properties of these 
instruments, which are used in practice and in research.  
Recommendation: 
 Use standardized IWS assessment instruments with proven clinical utility, validity, and reliability 
in infants and children; WAT-1 or the SOS (grade of recommendation = A) 
 
 
Delirium 
Delirium is a neuro-cognitive disorder due to a somatic illness or its treatment. According to DSM-5 
the core diagnostic criteria for delirium are (Table 1): a) a disturbance of attention or awareness; b) 
this disturbance is accompanied by changes in cognition that cannot be better accounted for by 
another pre-existing neurocognitive disorder (e.g., mental retardation, dementia); c) the condition 
develops within hours or days, and often fluctuates during the day, typically worsening in the 
eǀeŶiŶg ;’suŶdoǁŶiŶg’Ϳ; aŶd dͿ there are indications from the patient’s history, examination or 
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laboratory results that the disturbance is probably the result of a medical condition or its treatment. 
[61]. The pathogenesis of delirium is largely unknown. The sufferers may be hyperactive, hypoactive 
or show signs of both states. Typical for the hypoactive delirium are slowed or sparse speech, 
hypoactive or slowed motor activity as well as lethargy, also described as reduced awareness or 
apathy. Adults and children largely show the same symptoms although hallucinations and hypoactive 
delirium are hard to observe in the very young children [62]. However, delirium has been described 
in infants below 1 year of age [63]. Delirium has not been described in neonates to date. Increasing 
evidence suggests there is a positive association between illness severity and paediatric delirium 
[64]. Many risk factors for delirium have been identified. These can be classified as patient-related, 
iatrogenic, and environmental. Patient factors (e.g. infections, metabolic disorders, withdrawal from 
medications, restraints, and sleep disturbance) and environmental factors may contribute to 
developing delirium [56]. 
The reported prevalence of paediatric delirium (PD) in PICU patients is 4% to 29% [56, 65, 66]. 
Colville et al. found that three months after discharge one third of PICU patients reported memories 
of psychotic features, including delusions and disturbing hallucinations, suggestive of delirium during 
PICU admission [67]. Adult delirium has been associated with higher mortality and morbidity and 
longer length of hospital stay [68]. PD, too, is associated with longer length of stay [69] and – as we 
suspect – increased morbidity. Thus, early recognition of this serious neuropsychiatric disorder is 
essential, and PICU nurses could facilitate this task.  
Recommendation: 
 Search for potential sources of paediatric delirium and to take appropriate actions (grade of 
recommendation = D) 
 
Delirium assessment 
According to the literature, PD is under-diagnosed especially in young critically ill children [56]. A 
likely reason is that nurses and ICU-physicians do not specifically focus on the symptoms of PD; and 
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moreover, it is difficult to assess the symptoms in preverbal patients. Looking at behaviours has been 
suggested as an alternative [56, 63]. TakiŶg iŶto aĐĐouŶt the Đhild’s deǀelopŵeŶtal stages ŵakes it 
possible to reliably and accurately interpret alterations in behaviour, communication, and emotion in 
the critically ill child of any age [70]. A number of delirium symptoms overlap with those observed in 
other conditions, such as pain, distress and withdrawal syndrome [6]. Thus it would seem essential to 
use a reliable, validated and clinical useful bedside tool to screen delirium and guide treatment. This 
is an area of development but assessment instruments are already available. These are: 1) the 
pediatric Confusion Assessment Method for ICU (pCAM-ICU) for children of 5 years or older [66]; 2) 
the Cornwell Assessment Pediatric Delirium tool (CAP-D) for children of 0 up to 18 years of age [65, 
71]; and 3) the Sophia Observation withdrawal Symptoms-Pediatric Delirium scale [72, 73] (Table 5 
and supplementary file). In the lack of evidence, we recommend assessment of delirium at least once 
per shift or as indicated by the clinical condition of the child. 
Recommendation: 
 Use CAP-D as an instrument to assess paediatric delirium (grade of recommendation=A). 
 Together with the vital signs, delirium must be assessed and documented every 8 to 12 hours (at 
least once per shift) 24-48 hours after admission, or as indicated by the delirium score of clinical 
condition of the child (grade of recommendation = D). 
 
 
Pain and non-pain related distress management protocols in relation to assessment 
Effective pain and sedation management depends on the effectiveness of analgesics and sedatives, 
and the use of assessment instruments to measure the effects and target of the administered drugs. 
A number of randomized controlled trials have provided evidence for the use of individual drugs such 
as morphine, midazolam, paracetamol, clonidine and dexmedetomidine [74-77]. The combined use 
of drugs in infants has also been evaluated, like fentanyl versus remifentanil combined with 
midazolam [78] or remifentanil versus midazolam [79]. The use of fentanyl or morphine is common 
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practice around the world for postoperative analgesia in term newborns, infants and children, with 
recommended continuous infusions and dosages between 1-5 mcg/kg/h (fentanyl) and 10-40 
mcg/kg/h (morphine), respectively [8]. Opioids and/or benzodiazepines are often given during 
artificial ventilation. The use of morphine as the drug of first choice for postoperative analgesia has 
been debated given the equipotency of intravenous paracetamol as the drug of first choice. With 
regards to sedation, Curley et al. failed to show beneficial effects of protocolized sedation versus 
usual care on length of artificial ventilation in a multicenter cluster randomised study of 31 PICUs in 
the US [80]. Still, daily interruption of sedatives significantly improved short- and long-term 
outcomes in adults. All evidence indicates that the use of sedatives should be reduced. In children, 
daily interruption of sedation seems feasible and safe [81, 82]. However, the effectiveness needs to 
be demonstrated in large trials [83]. Following the evaluation of the level of evidence of analgesic 
and sedative drugs by Playfor (2006) [8], increased attention is being paid to optimal dosing of many 
of the drugs used routinely in the PICUs around the world. Studies have demonstrated that re-
assessment after an intervention is often neglected, although it is crucial in evaluating whether an 
intervention is effective or not [84, 85]. In summary, the overall aim of assessment of pain and non-
pain related distress in relation to treatment is to find the most appropriate dose for the individual 
patient to eliminate or reduce pain and discomfort to an acceptable level  without side effects of 
therapy. Therefore, we recommend that the effect of a drug (e.g. increasing or decreasing of a pump, 
bolus) is re-eǀaluated depeŶdiŶg oŶ the drug’s half-life. One value outside the normal range of the 
score should not immediately result into a change in drug dosages. Strategies to reduce the incidence 
of iatrogenic withdrawal syndrome should begin by making efforts to reduce doses of 
benzodiazepines and/or opioids, and thereby preventing oversedation [44, 86].  
Recommendation: 
 The effect (e.g. increasing or decreasing of a pump, bolus) of a drug should be re-evaluated 
depending on the drug’s half-life (grade of recommendation = D). 
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A weaning strategy for gradual decreasing of opioid and/or benzodiazepine dosages is essential to 
prevent IWS. Strategy options include slowly tapering off the intravenous infusion rate or using an 
alternative route, like the enteral or subcutaneous route. However, the evidence of different 
strategies is scarce. At each step in the weaning process, possible withdrawal symptoms should be 
carefully monitored with the help of the WAT-1 or SOS. 
Recommendation: 
 Re-assess for symptoms of withdrawal after treatment interventions (grade of recommendation = 
D).  
 
Delirium in PICU patients has been treated with haloperidol and risperidone and both drugs 
demonstrated beneficial effects without significant side effects [56]. There remains a need for well-
designed, randomized, placebo-controlled trials assessing the efficacy and safety of delirium drug 
therapy. Clinical pharmacological principles should go hand in hand with the daily use of validated 
assessment instruments with good psychometric properties. In this way optimal dosing and 
evaluation of specific behaviours of the individual critically ill patient will result in optimal synergy 
between care and cure. 
Recommendation:  
 Validated assessment tools for pain, sedation, withdrawal syndrome and delirium should be 
integrated in pain and non-pain related treatment protocols (grade of recommendation = C). 
 
 
Discussion and conclusion 
Providing comfort and minimizing anxiety, fear and distress in critically ill infants and children is an 
important part of the daily activities of intensive care nurses. These patients, who are unable to 
communicate their pain, discomfort, anxiety and fear, are at great risk for inadequate analgesia, 
sedation or delayed recognition of withdrawal syndrome and/or delirium. Just like all infants and 
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children, this special population deserves consistent, on-going assessment and re-assessment of 
interventions to confirm the best possible treatment for pain, distress, inadequate sedation, 
withdrawal syndrome and delirium. This position paper offers recommendations to this aim. To 
achieve the best possible outcome, interdisciplinary collaboration of nurses, physicians, and hospital 
pharmacists/clinical pharmacologists is therefore warranted. Distress can be reduced by creating an 
optimal environment with little noise (<45dB), favourable conditions for day-night (sleep) rhythm in 
combination with day-light, and family presence [87]. However, more research is needed to establish 
the effectiveness of non-pharmacological interventions in critically ill children. Furthermore, the 
nursing role includes providing information to parents, asking them about the nature and intensity of 
pain and distress of their infant or child, and consequently listening to parents. This requires a 
particular awareness, knowledge of and insight into these phenomena. It may be difficult to 
discriminate between pain, distress, IWS and delirium in critically ill children, because the behavioral 
cues will overlap in part (Figure 1). Pain frequently results in distress, but distress may have other 
causes than pain. Despite their close association, distinguishing between these concepts is clinically 
important as they are treated differently. A behavioral tool that is able to discriminate pain, sedation, 
iatrogenic withdrawal syndrome, and delirium in all circumstances is not available. It could be 
challenging for clinicians to deal with all these different instruments. The decision to apply a 
particular instrument should always be driven by interpreting factors related to the context of the 
patient (e.g. use of sedatives, postoperative, prolonged administration of sedatives/opioids as a risk 
for IWS), environment, and response to therapies (See Figure 2). Combining this with the different 
scores then allows to decide on the necessary action.  
As the evidence for several recommendations is poor (e.g. grade D recommendations) further 
research is needed to strengthen these recommendations. Clinicians are recommended to select a 
validated and reliable assessment instrument and could be guided in the choice by the grade of 
recommendation. Furthermore, other factors should be considered like the ease of use, complexity 
of the tool, and the time it takes to complete the assessment. All staff working on the NICU or PICU 
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(physicians, nurses and nursing support staff) should be trained in the application of these 
instruments. Further, assessment outcomes should be integrated in treatment decision trees with 
recommended dosages based on RCTs in paediatric patients.  In addition to pain as the 5
th
 vital sign, 
it may be time to also endorse non-pain related distress in critically ill infants and children as the 
composite 6
th
 vital sign [88]. 
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Table 1 Definitions of pain, distress, withdrawal syndrome, and delirium 
Definitions of pain, distress, iatrogenic withdrawal syndrome, and delirium 
Pain  
͞AŶ uŶpleasaŶt seŶsorǇ aŶd eŵotioŶal eǆperieŶĐe assoĐiated ǁith aĐtual or poteŶtial tissue daŵage, or 
described in terms of such damage. Note: The inability to communicate verbally does not negate the 
possibility that an individual is experiencing pain and is in need of appropriate pain-relieǀiŶg treatŵeŶt.͟ 
(IASP, 2014) 
Acute pain: ͞AĐute paiŶ should ďe ǀieǁed as the iŶitiatioŶ phase of aŶ eǆteŶsiǀe, persisteŶt ŶoĐiĐeptiǀe aŶd 
behavioural cascade triggered by tissue injury. This cascade has the potential to span orders of magnitude of 
spaĐe aŶd tiŵe, ďut geŶerallǇ suďsides ǁithiŶ ǁeeks͟ [89]  
Postoperative pain acute pain experienced post-surgery 
Prolonged pain: The terms prolonged and recurrent are used interchangeably in the literature. Prolonged or 
persistent pain is primarily caused by disease e.g. peritonitis. Prolonged pain differs from chronic pain in that 
there is a clear stimulus caused by disease (e.g. peritonitis) or therapy (e.g. mechanical ventilation, insertion of 
tubes or drains), with a clear definable beginning and an expected endpoint. But less than 3 months and full 
recovery of tissue damage can be expected, which is not the case in chronic pain[23]. 
 
Non-pain related distress 
Distress is aŶ orgaŶisŵ’s respoŶse to aǀersiǀe iŶterŶal aŶd eǆterŶal stiŵuli aŶd ŵaǇ iŶĐlude disĐoŵfort, 
aŶǆietǇ, aŶd fear͟ [25].  
Optimal sedation: a state in which the patient is somnolent, responsive to the environment but untroubled by 
it, and with no excessive movements [13]. 
 
Iatrogenic withdrawal syndrome 
A clinical syndrome that manifests after stopping or reversing a drug after prolonged exposure to that drug [3, 
4]. 
Tolerance: a deĐrease iŶ a drug’s effeĐt or the Ŷeed to iŶĐrease the dose to aĐhieǀe the saŵe effeĐt [ϯ, ϰ].  
Physiological dependence:  the requirement for continued administration of a sedative or analgesic to prevent 
signs of withdrawal syndrome. 
 
Delirium 
A neuro-cognitive disorder due to a somatic illness or its treatment [61] 
DSM-V criteria: 
A. Disturbance in attention (i.e., reduced ability to direct, focus, sustain, and shift attention) and awareness 
(reduced orientation to the environment). 
B. The disturbance develops over a short period of time (usually hours to a few days), represents an acute 
change from baseline attention and awareness, and tends to fluctuate in severity during the course of a day. 
C. An additional disturbance in cognition (e.g. memory deficit, disorientation, language, visuospatial ability, or 
perception). 
D. The disturbances in Criteria A and C are not better explained by a pre-existing, established or evolving 
neurocognitive disorder and do not occur in the context of a severely reduced level of arousal such as coma. 
E. There is evidence from the history, physical examination or laboratory findings that the disturbance is a 
direct physiological consequence of another medical condition, substance intoxication or withdrawal (i.e. due 
to a drug of abuse or to a medication), or exposure to a toxin, or is due to multiple etiologies. 
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Table 2: Panel of Behavioral instruments specific to paediatric critical care 
COMFORT behavior scale 
Categories 
Alertness 
Calmness/agitation 
Respiratory response or crying* 
Physical movement 
Muscle tone 
Facial tension 
 
Score 
1-5 
1-5 
1-5 
1-5 
1-5 
1-5 
Total score 6-30 
Withdrawal Assessment Tool 
Information from patient record 
Loose /watery stools 
Vomiting/retching/gagging 
Temperature > 37.8° 
2 minute pre-stimulus observation 
State
*
 
Tremor  
Any sweating 
Uncoordinated/repetitive movement 
Yawning of sneezing 
1 minute stimulus observation 
Startle to touch 
Muscle tone 
Post-stimulus recovery 
Tiŵe to gaiŶ Đalŵ state ;“B“ ч ϬͿ 
 
 
No=0, yes=1 
No=0, yes=1 
No=0, yes=1 
 
“B“чϬ = Ϭ, “B“шϭ =ϭ  
No=0, moderate/severe=1 
No=0, yes=1 
No=0, moderate/severe=1 
No=0, yes=1 
 
No=0, moderate/severe=1 
Normal=0, increased=1 
 
0-2 
Total score 0-12 
Sophia Observation withdrawal Symptoms-scale 
Items 
Autonomic dysfunction 
Tachycardia 
Tachypnea 
Feǀer ;ш ϯ8.ϱ°Ϳ 
Sweating 
CNS irritability 
Agitation 
Anxiety 
Tremors 
Increased muscle tension 
Inconsolable crying 
Grimacing 
Sleeplessness  
Motor disturbance 
Hallucinations 
Gastrointestinal dysfunction 
Vomiting 
Diarrhea 
 
 
Score 
 
No=0, yes=1 (for all items) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total score 0-15 
*Crying only in spontaneous breathing children 
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Table 3 Pain: Summary of recommended assessment tools for neonates and critically ill children 
 NEONATES INFANTS & CHILDREN 
 PIPP[90-92] PIPP-Revised [40, 41] 
 
N-PASS [93, 94]  COMFORTneo [95] COMFORT behavior scale 
[26, 29, 31, 33] 
FLACC [35, 96] Multidimensional 
Assessment of Pain Scale 
(MAPS)[36, 97]  
Age range  28-40 weeks 
 
28-40 weeks 
 
23-40 weeks  
 
24-42 weeks 0-3 years 0-7 years 
 
0-31 months  
Type of pain Procedural   and 
postoperative pain 
Procedural pain Procedural and 
prolonged pain 
 
Prolonged pain Postoperative pain Postoperative pain Postoperative pain 
Variables 
assessed 
 
 
Heart rate*, 
Oxygen saturation *, 
Brow bulge, *  
Eye squeeze * 
Nasolabial furrow*, 
Behavioral state 
Heart rate*, 
Oxygen saturation*, 
Brow bulge
ⱡ
, 
Eye squeeze
ⱡ
, 
Nasolabial furrow
ⱡ
, 
Behavioral state 
Heart rate, 
Respiratory rate, 
Blood pressure, 
Oxygen saturation 
Crying, irritability, 
Facial expressions, 
Behavioral state, 
Extremities/tone 
 
Alertness, 
Calmness/agitation, 
Respiratory response or 
crying, 
Body movement, 
Muscle tone, 
Facial tension 
 
 
Alertness, 
Calmness/agitation, 
Respiratory response or 
crying, 
Physical movement, 
Muscle tone, 
Facial tension 
 
Facial expression, 
Movement of limbs,  
Cry, Consolability 
 
 
Vital signs HR 
aŶd ⁄ or BP, 
Breathing pattern, 
Facial expression, 
Body movements, 
State of arousal 
Score range  
(cut off point) 
0-21 
0-6 No to mild pain 
7-12 moderate pain  
>12 severe pain 
0-21 
0-6 No to mild pain 
7-12 moderate pain  
>12 severe pain 
Pain: 0-10 
>3 
6-30 
6-13 no to mild 
discomfort 
14-21 moderate 
discomfort 
>22 severe discomfort 
6-30 
>17 pain 
0-10 
1-3 mild discomfort 
4-6 moderate 
discomfort 
6-10 Severe discomfort/ 
pain 
 
Adjustment for 
gestational age 
Yes Yes** Yes 
 
No NA NA NA 
Reliability data + - + + + + + 
Forms of validity 
established 
Construct and 
concurrent 
Construct and 
concurrent 
Construct and 
convergent 
Concurrent Construct and concurrent  Construct and concurrent 
Clinical utility + - + + +   
GRADE A A B B A  B A 
*Changes expressed in % (in PIPP used to look at heart rate increases only but the revised version also takes heart rate declines into account); 
ⱡ
changes expressed in seconds; ** only if the 
score on the other items >0   
See supplemental file for detailed data regarding psychometric properties. 
  
30 
 
Table 4 Sedation: summary of recommended assessment tools for critically ill children 
 COMFORT scale [25, 45, 98] COMFORT behavior scale 
[14, 31, 32, 42, 99] 
State Behavioral Scale (SBS) 
[46] 
Age range  0-16 years 
Distress 
 0-16 years 
Distress 
6 weeks-6 years 
Variables 
assessed 
Heart rate, 
Mean arterial pressure, 
Alertness, 
Calmness, 
Respiratory response, 
Movement, 
Muscle tone, 
Facial expression 
Alertness, 
Calmness/agitation 
Respiratory response or 
crying 
Physical movement, 
Muscle tone, 
Facial tension 
Respiratory drive, 
Coughing, 
Best response to stimuli, 
Attentiveness to care 
provider, 
Tolerance to care, 
Consolability, 
Movement after consoled 
Score range  
(cut off point) 
8-40 
<17 oversedation 
17-26 optimal sedation 
>26 undersedation 
6-30 
<11 oversedation 
11-22 adequate sedation 
>22 undersedation 
6-point scale; state behavior 
on a scale of -3 to +2 
0 = Awake and calm 
Reliability data + + + 
Forms of validity 
established 
Face, construct and 
concurrent 
Face, construct and 
concurrent, responsiveness 
Face, construct 
Clinical utility  Feasibility and utility 
established bedside 
Feasibility and utility 
established bedside 
Grade A A B 
See supplemental file for detailed data regarding psychometric properties. 
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Table 5 IWS and Delirium: summary of recommended assessment tools for critically ill children  
 Withdrawal Assessment Tool 
version-1 (WAT-1) [57, 58] 
Sophia Observation withdrawal 
Symptoms-scale (SOS) [59, 60] 
Pediatric Confusion 
Assessment Method-Intensive 
Care Unit (pCAM-ICU) [66] 
Cornell Assessment 
Pediatric-Delirium (CAP-D) 
[65, 71] 
Sophia Observation withdrawal 
Symptoms-Pediatric Delirium 
scale (SOS-PD) [72, 73] 
Age range  Children 0-16 years Children 0-16 years 5-16 years 0-21 years 0-16 years 
Variables assessed Loose /watery stools 
Vomiting/retching/gagging 
Temperature > 37.8° 
State
*
 
Tremor 
Sweating 
Uncoordinated/repetitive 
movement 
Yawning of sneezing 
Startle to touch 
Muscle tone 
Tiŵe to gaiŶ Đalŵ state ;“B“ ч ϬͿ 
Tachycardia 
Tachypnea 
Feǀer ;ш ϯ8.ϱ°Ϳ 
Sweating 
Agitation 
Anxiety 
Tremors 
Increased muscle tension 
Inconsolable crying 
Grimacing 
Sleeplessness  
Motor disturbance 
Hallucinations 
Vomiting 
Diarrhea 
Four features: 
Acute change or fluctuation 
course of mental status, 
Inattention, 
Altered level of consciousness, 
Disorganized Thinking. 
Eye contact with caregiver, 
Purposeful actions, 
Awareness of surrounding, 
Communicate needs, 
Restless, 
Inconsolable, 
Underactive, 
Response to interaction. 
 
Agitation (restless), Anxiety, eye 
contact, grimacing,  
impaired attention,  
Speech, 
Tremors, 
Muscle tone, 
Purposeful actions, 
Sleeplessness, 
Hallucinations, 
Disorientation, 
Sweating, 
Acute change / fluctuation, 
Parents.  
 
Score range  
(cut off point) 
0-12 points 
шϯ 
0-15 points 
шϰ 
Features 1, 2 and 3 or 4 
positive = delirium; or feature 1 
and negative = no delirium*  
0-40  
(9)  
0-15  
(4) 
Reliability data + + + + +/- 
Forms of validity 
established 
Content, construct, responsiveness Face, construct Criterion Criterion Face (Criterion pilot) 
Clinical utility Feasibility and utility established 
bedside 
Feasibility and utility established 
bedside 
Feasibility Utility established bedside Feasibility 
GRADE A A B A C 
See supplemental file for detailed data regarding psychometric properties. 
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Figure 1: Overlap behavioural cues in pain, sedation, withdrawal syndrome and delirium. 
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Figure 2:  
 
 
Interpretation pain and non-pain related distress in critically ill children, based on van Dijk et al. 2012 [16] 
